|
|
Bird Flu (Avian Influenza)
Main Page
Avian
Flu (Avian Influenza)

Frequently Asked Questions About Pandemic Influenza
-
What is an
influenza pandemic?
A pandemic is a global disease outbreak. An influenza
pandemic occurs when a new influenza A virus emerges for
which there is little or no immunity in the human
population, begins to cause serious illness and then
spreads easily person-to-person worldwide.
-
How do
pandemic viruses occur?
New influenza viruses emerge as a result of a process
called antigenic shift, which causes a sudden and major
change in influenza A viruses. These changes occur when
proteins on the surface of the virus combine in new ways
as a result of mutation or exchange of genetic material
between multiple influenza viruses. If such changes
result in a new influenza A virus subtype that can
infect humans and spread easily from person to person,
an influenza pandemic can occur.
-
Is a pandemic
imminent?
Many scientists believe it is a matter of time until the
next influenza pandemic occurs. However, the timing and
severity of the next pandemic cannot be predicted.
Influenza pandemics occurred three times in the past
century — in 1918-19, 1957-58, and 1968-69.
-
Why is there
concern about the H5N1 avian influenza outbreak in Asia
and other countries?
Although it is unpredictable when the next pandemic will
occur and what strain may cause it, the continued and
expanded spread of a highly pathogenic—and now
endemic—avian H5N1 virus across eastern Asia and other
countries represents a significant threat.
Avian H5N1 influenza infection in humans was first
recognized in 1997 when this virus infected 18 people in
Hong Kong, causing 6 deaths. Concern has increased in
recent years as avian H5N1 infections have killed large
numbers of poultry flocks and other birds in Asia and
Europe. Since 2003, more than 100 human H5N1 cases have
been reported in Thailand, Vietnam, Cambodia, Indonesia,
China, Turkey, and Iraq, and more than half have died.
The H5N1 virus has raised concerns about a potential
human pandemic because:
-
The H5N1 virus is widespread
in poultry in many countries in Asia and has spread to
Europe;
-
The virus has been
transmitted from birds to mammals and in some limited
circumstances to humans;
-
Wild birds and domestic
ducks have been infected without showing symptoms and
become carriers of viral infection to other domestic
poultry species;
-
There a few cases of
human-to-human transmission have been reported; and
-
Genetic studies confirm that
H5N1 influenza viruses, like other influenza viruses,
are continuing to evolve.
-
Is influenza A
(H5N1) virus the only avian influenza virus of concern
regarding a pandemic?
Although H5N1 probably poses the greatest current
pandemic threat, other avian influenza A subtypes also
have infected people in recent years. For example, in
1999, H9N2 infections were identified in Hong Kong; in
2002; and 2003, H7N7 infections occurred in the
Netherlands and H7N3 infections occurred in Canada.
These viruses also have the potential to give rise to
the next pandemic.
-
Will H5N1
cause the next influenza pandemic?
Scientists cannot predict whether an avian influenza
(H5N1) virus will cause a pandemic. That is why we are
focusing on comprehensive public health efforts —
increasing surveillance monitoring for outbreaks,
international cooperation, antiviral and vaccine
stockpiles and building more robust capacity for vaccine
production — that will help protect us no matter what
pandemic strain emerges or where.
-
Why won't the
annual flu vaccine protect people against pandemic
influenza?
Influenza vaccines are designed to protect against a
specific virus, so a pandemic vaccine cannot be produced
until a new pandemic influenza virus emerges and is
identified. Even after a pandemic influenza virus has
been identified, it could take at least 6 months to
develop, test and produce vaccine.
-
How much time
does it take to develop and produce an influenza
vaccine?
The influenza vaccine production process is long and
complicated. Traditional influenza vaccine production
for the U.S. relies on long-standing technology based on
chicken eggs. This production technology is
labor-intensive and takes 9 months from start to finish.
The flu vaccine production process is further
complicated by the fact that influenza virus strains
continually evolve. Thus, seasonal flu vaccines must be
modified each year to match the strains of the virus
that are known to be in circulation among humans around
the world. As a result of this constant viral evolution,
seasonal influenza vaccines cannot be stockpiled year to
year.
The appearance of an influenza pandemic virus would
likely be unaffected by currently available flu
vaccines. Researchers are making and testing possible
H5N1 vaccines now.
Large amounts of vaccine cannot be made before knowing
exactly which virus will cause the pandemic. It could
then take up to 6 months before a vaccine is available
and in only limited amounts at first. Research is
underway to make vaccines more quickly.
-
How many
influenza vaccine manufacturers have production
facilities in the United States?
Currently, Sanofi Pasteur and Medimmune have influenza
vaccine production facilities in the United States,
although only Sanofi Pasteur's entire production process
is based in this country.
HHS has made the establishment and expansion of
U.S.-based manufacturing facilities for influenza
vaccine a key component of its strategy to improve the
security of the influenza vaccine supply.
-
How will
vaccine be distributed if a pandemic breaks out?
Most likely, the federal government will work with
manufacturers, distributors and states and the states
will develop distribution plans at the local level.
States are developing and improving plans to distribute
a vaccine rapidly. These plans build on experience
gained from other emergencies.
In addition, influenza vaccine makers already have
systems in place to distribute vaccine. Tens of millions
of doses of seasonal influenza vaccine are shipped every
year, and during past shortages, vaccine makers have
responded to urgent situations.
Fairness in vaccine distribution and use during a
pandemic is important. Protecting people at high risk
and protecting essential day-to-day services are also
important considerations.
-
What age
groups are most likely to be affected during an
influenza pandemic?
Although scientists cannot predict the specific
consequences of an influenza pandemic, it is likely that
many age groups would be seriously affected. Factors to
consider include the following:
-
Few if any people would have
immunity to the virus
-
The virus could spread
rapidly.
-
An influenza pandemic could
temporarily disrupt activities important to overall
public health, the economy, and essential community
services.
-
What is the
difference between a vaccine and an antiviral?
Vaccines are usually given as a preventive measure.
Currently available viral vaccines are usually made from
either killed virus or weakened versions of the live
virus or pieces of the virus that stimulate an immune
response to the virus. When immunized, the body is then
poised to fight or prevent infection more effectively.
Antivirals are drugs that may be given to help prevent
viral infections or to treat people who have been
infected by a virus. When given to treat people who have
been infected, antiviral medications may help limit the
impact of some symptoms and reduce the potential for
serious complications, especially for people who are in
high risk groups.
-
How would
antivirals be used?
Antivirals may help prevent infection in people at risk
and lessen the impact of symptoms in those infected with
influenza. It is unlikely that they would substantially
modify the course or effectively contain the spread of
an influenza pandemic.
A number of antiviral medications (antivirals) are
approved by the U.S. Food and Drug Administration to
treat and sometimes prevent flu. At this time, Tamiflu®
and Relenza® are the most likely antivirals to be used
in a pandemic. There are efforts to find new drugs and
to increase the supply of antivirals. If everyone
follows the recommended uses of antivirals there will be
more available for those who need it most.
-
What other
strategies will help protect Americans?
In the event of a pandemic, certain public health
measures may be important to help contain or limit the
spread of infection as effectively as possible. The
following actions could include:
-
Treating sick and exposed
people with antivirals,
-
Isolating sick people in
hospitals, homes, or other facilities,
-
Identifying and quarantining
exposed people,
-
Closing schools and
workplaces as needed,
-
Canceling public events, and
-
Restricting travel.
In addition, people should protect themselves by:
-
Getting seasonal flu shots,
-
Washing hands frequently
with soap and water,
-
Staying away from people who
are sick, and
-
Staying home if sick.
-
How many
people would die in a pandemic?
The consequences of an influenza pandemic are difficult
to predict. Pandemics occurred three times in the past
century. The most recent (1968) was the mildest and
killed about 34,000 people in the United States. The
most severe influenza pandemic in the past century
occurred in1918 and killed about 500,000 Americans and
up to 40 million people worldwide.
-
Could
terrorists spread the avian influenza viruses to create
a worldwide pandemic?
Experts believe it highly unlikely that a pandemic
influenza virus could be created by terrorists.
Developing a pandemic influenza virus would require
extraordinary scientific skill as well as sophisticated
scientific equipment and other resources.
-
What is the
Government doing now to prepare for a pandemic flu
outbreak?
Federal, State, and local health agencies are making
plans to prepare for, respond to, and contain an
outbreak of pandemic flu. HHS activities to prepare for
a pandemic flu include:
-
Supporting Federal, State,
and local health agencies' efforts to prepare for and
respond to a pandemic flu outbreak;
-
Working with the World
Health Organization (WHO) and other nations to help
detect and contain outbreaks;
-
Developing a national
stockpile of antiviral drugs to help treat and control
the spread of disease;
-
Supporting the manufacture
and testing of possible vaccines, including finding more
reliable and quicker ways to make large quantities of
vaccines; and
-
Working with other Federal
agencies to prepare and to encourage communities,
businesses, and organizations to plan for a pandemic
influenza outbreak.
-
How many state
and local governments are prepared for a pandemic
outbreak?
Funding from CDC's Public Health Preparedness
Cooperative Agreements has allowed state and local
health agencies to enhance the capacity of their public
health systems to respond to public health threats,
including pandemic influenza.
All states have emergency plans for responding to an
influenza pandemic. All states have reviewed their
public health legal authorities pertaining to isolation
and quarantine. States are in various phases of updating
regulations and legislation after reviewing their
current authorities. CDC's Public Health Law program is
cataloging all state quarantine authorities.
As part of planning for smallpox, all states have
developed plans for mass immunization. In the past 12
months, all states conducted exercises to test
components of their smallpox plans and 46 conducted
exercises related to components of their pandemic
influenza plan. Exercises such as these allow states and
communities to identify weaknesses and take corrective
action.
-
How would
pandemic flu affect communities and businesses?
If an influenza pandemic occurs, many people could
become sick at the same time and would be unable to go
to work. Many would stay at home to care for sick family
members. Schools and businesses might close to try to
prevent disease spread. Large group gatherings might be
canceled. Public transportation might be scarce. These
are examples of challenges that local communities,
schools, civic organizations, and businesses will have
to work together on to plan for a pandemic response.
|